John Leppert

Opportunity for a new Director of the Institute of Urologic Oncology (IUO) at UCLA (uclahealth.org/departments/ur…) Seeking the best and brightest (internally/externally) to lead this multi-D clinical, academic, and educational engine To learn more and apply: recruit.apo.ucla.edu/JPF10718

Physicians have dealt with a 29% real decline in Medicare reimbursements over the past two decades, even as practice expenses (like staffing, equipment, and malpractice insurance) have risen faster than inflation This proposed cut is akin to telling a factory worker, “Great job automating the line to boost output. Here’s a pay cut because you’re too productive now.” Urology community: make your voice heard now. Like and retweet… extend the reach. Don’t assume others will do it.

excited to start on editorial board @JUrology and fun to see it in print ! I hope to live up to the legacy of Dr Grayhack, my first urology mentor @NorthwesternMed. I'm always open to hear new ideas and research to champion ! @StanfordUrology @AmerUrological

We are seeking a fellowship-trained endourologist to join our faculty as an Assistant Professor in the University Medical Line. Click below for details and to apply. facultypositions.stanford.edu/en-us/job/4949… @StanfordMed @jessiege_ @Belay_RE @JayOgunk @Ama_Ndumele @sherry_lu5 @julianakim04 @TommyJiang_2023 @Annie_Zwaschka @StanfordMed @liaojoe1 @geoffsonn @contisimon @DrEnemchukwu @DrBenjaminChung @DrMEisenberg @DonaldDeglover @GuolanLu @johnleppert @twiropa @ShkolyarE @AmerUrological

@grahamserwin congrats !!

Proud to announce that we received the NIH Director's New Innovator Award to develop a new class of genome editing tools!

📢 Apply now for a joint award from #RisingTideFoundation and the KCA for "Early Detection and Diagnosis in #KidneyCancer"! 👉Award of up to $150K per project over 2 yrs. 👉Letters of Intent due October 15. 👉 Full details bit.ly/4l5XepX

Trump Is Shutting Down the War On Cancer nytimes.com/2025/09/14/mag… via @NYTimes

🌹Meet #ROSIE, our new AI that predicts spatial multi-protein expression straight from routine H&E images. Built on a large co‑staining dataset (>1k samples, 16M+ cells). It enables cell phenotyping & tissue structure insights w/o extra assays.

Editorial by @gchertow: Embracing the Generational Opportunity to Improve the Care of Kidney Disease bit.ly/3RPQKyM (FREE) @StanfordNeph

@AmerUrological great work from @SoerensenSimon @StanfordUrology @StanfordEpiNews

According to a #AUA25 Press Program abstract, among the 6 PFAS compounds analyzed in the study, county-level exposure to 5 individual PFAS chemicals was significantly associated with increased incidence of bladder cancer. Hear more from the author 👉 bit.ly/3Tzied4

Backed by a $100M gift from Joan and Sandy Weill, UCSF and @StanfordMed @StanfordCancer are launching Weill Cancer Hub West, a $200M initiative in team science to accelerate cancer research and improve care over the next decade. tiny.ucsf.edu/ppVRqt

In Memory of Dr. Christopher Julian (Stanford Urology Resident, 1993–1997) We are deeply saddened to share the news of the sudden passing of Dr. Christopher Julian on 6/29/25, a beloved member of our alumni community and former Stanford Urology resident from 1993 to 1997. Dr. Julian earned his bachelors degree from University of California, Berkeley, and received his MD from Georgetown University. He returned to California to complete his residency training at Stanford Urology, where he distinguished himself not only as a dedicated clinician but also as a guest lecturer in the Department of Physiology. The son of well-known Fresno urologist Dr. Robert Julian, Chris joined him after residency to co-found the Urology Associates of Central California. Together, father and son became pillars of specialized care in urology and leaders in their community. In recognition of his impact, he was honored in 2008 with Fresno Magazine’s “Best in Fresno” award, selected by local primary care physicians as the top urologist in the area. He maintained close connections to our department throughout his career. We all recognized him as an outstanding local physician who took great care of our mutual patients. Beyond his clinical work, he was a devoted husband to his wife Julie and father to their daughter. He regularly spent time golfing with his father and skiing and vacationing with his family. Dr. Julian’s sudden passing is a profound loss to the Fresno medical community and to all of us who had the privilege of knowing him. We extend our heartfelt condolences to his family, colleagues, and loved ones during this difficult time. @StanfordMed @_AHerbertMD @steveranzhou @jessiege_ @Belay_RE @JayOgunk @Ama_Ndumele @sherry_lu5 @julianakim04 @TommyJiang_2023 @Annie_Zwaschka @StanfordMed @StanfordCME @liaojoe1 @geoffsonn @contisimon @DrEnemchukwu @DrBenjaminChung @DrMEisenberg @DonaldDeglover @f_delgiudice @GuolanLu @johnleppert @twiropa @ShkolyarE

Celebrating our 2025 graduating Chiefs and Fellows! We are so proud of you, and as your new journey begins, remember, you're always part of the Stanford Urology Family. @_AHerbertMD @steveranzhou @jessiege_ @Belay_RE @JayOgunk @Ama_Ndumele @sherry_lu5 @julianakim04 @TommyJiang_2023 @Annie_Zwaschka @StanfordMed @StanfordCME @liaojoe1 @geoffsonn @contisimon @DrEnemchukwu @DrBenjaminChung @DrMEisenberg @DonaldDeglover @f_delgiudice @GuolanLu @johnleppert @twiropa @ShkolyarE

Come by Poster 85 @AcademyHealth #ARM25 to discuss how an intervention to #deimplement #lowvaluecare among Veterans with #prostatecancer had different effects among various #healthcareproviders

Veterans enrolled in high-veteran Medicare Advantage plans are more likely to have their surgical care costs shifted to the Veterans Health Administration instead of being covered by the MA plans. #ARM25 @AcademyHealth ja.ma/4kOsObr

@MikeUmbro sorry in advance youtu.be/LRWAFQqQY9Y?si…

“Did you know that every tortoise is a turtle, but not every turtle is a tortoise?” -Kernel the Turtle 🐢

congrats to @CamEAlexander and team !

@EvanThomas84 @SPuro88 @shaker_leonard I worry this approach is a recipe to worsen the problem of overtreatment in men with limited life expectancy ... which is already rising pubmed.ncbi.nlm.nih.gov/39527047/

@SPuro88 @shaker_leonard We disagree. Hopefully this will incentivize the USPTF and AAFP to re-examine the updated evidence and restore previous screening guidelines. Most 80yo would be happy to take a biopsy and 5 treatments of radiation than risk a de novo stage IV diagnosis.

I wonder how much today’s news is going to spike up PSA screening in 80+ year olds with less than 10 year life expectancy.

@SPuro88 this is a call to generate a statement to suggest appropriate steps for men outside screening age with elevated PSA... Is imaging to r/o metastatic disease a better goal in men with limited life expectancy? published with Dr Bergman and @BogdanaSchmidt... sciencedirect.com/science/articl…